Picture of Ensysce Biosciences logo

ENSC — Ensysce Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Ensysce Biosciences Receives Notice Of Award For Year Three Of Multi-Year Nida Grant For Development Of Its Next Generation Opioid Products

July 8 (Reuters) - Ensysce Biosciences Inc  ENSC.O :
    * ENSYSCE BIOSCIENCES RECEIVES NOTICE OF AWARD FOR YEAR
THREE OF
MULTI-YEAR NIDA GRANT FOR THE CLINICAL DEVELOPMENT OF ITS NEXT
GENERATION OPIOID PRODUCTS WITH OVERDOSE PROTECTION
    * ENSYSCE BIOSCIENCES INC - AN ADDITIONAL $2.8 MILLION AWARD
FOR
YEAR FOUR IS PENDING.
    * ENSYSCE BIOSCIENCES INC - AWARD WILL PROVIDE $2.8 MILLION
TO
INITIATE A PHASE 1 STUDY OF FIRST MPAR OVERDOSE PROTECTION
PRODUCT IN U.S., PF614-MPAR

Source text for Eikon:  ID:nGNX1HB7SL 
Further company coverage:  ENSC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ensysce Biosciences

See all news